Dyslipidemia and cardiovascular disease risk among the MASHAD study population

Mahshad Hedayatnia(Mashhad University of Medical Sciences), Zahra Asadi(Mashhad University of Medical Sciences), Reza Zare‐Feyzabadi(Mashhad University of Medical Sciences), Mahdiyeh Yaghooti‐Khorasani(Mashhad University of Medical Sciences), Hamideh Ghazizadeh(Mashhad University of Medical Sciences), Roshanak Ghaffarian‐Zirak(Mashhad University of Medical Sciences), Abolfazl Nosrati‐Tirkani(Mashhad University of Medical Sciences), Maryam Mohammadi‐Bajgiran(Mashhad University of Medical Sciences), Mohadese Rohban(Mashhad University of Medical Sciences), Fatemeh Sadabadi(Mashhad University of Medical Sciences), Hamid Reza Rahimi(Mashhad University of Medical Sciences), Marzieh Ghalandari(Mashhad University of Medical Sciences), Mohammad-Seddigh Ghaffari(Mashhad University of Medical Sciences), Asa Yousefi(Mashhad University of Medical Sciences), Elnaz Pouresmaeili(Mashhad University of Medical Sciences), Mohammad-Reza Besharatlou(Mashhad University of Medical Sciences), Mohsen Moohebati(Mashhad University of Medical Sciences), Gordon A. Ferns(Brighton and Sussex Medical School), Habibollah Esmaily(Mashhad University of Medical Sciences), Majid Ghayour‐Mobarhan(Mashhad University of Medical Sciences)
Lipids in Health and Disease
March 16, 2020
Cited by 372Open Access
Full Text

Abstract

INTRODUCTION: Dyslipidemia may be defined as increased levels of serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), or a decreased serum high-density lipoprotein cholesterol (HDL-C) concentration. Dyslipidemia is an established risk factor for cardiovascular disease (CVD). We aimed to investigate the association of dyslipidemia and CVD events among a population sample from Mashhad, in northeastern Iran. MATERIAL AND METHODS: This prospective cohort study comprised a population of 8698 men and women aged 35-65 years who were recruited from the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) study. Socioeconomic and demographic status, anthropometric parameters, laboratory evaluations, lifestyle factors, and medical history were gathered through a comprehensive questionnaire and laboratory and clinical assessment for all participants. Cox regression model and 95% confidence interval (CI) were used to evaluate the association of dyslipidemia and its components with CVD incidence. RESULTS: After 6 years of follow-up, 233 cases of CVD (including 119 cases of unstable angina [US], 74 cases of stable angina [SA], and 40 cases of myocardial infarction [MI]) were identified in the study population. Unadjusted baseline serum LDL-C, TC, and TG levels were positively associated with the risk of total CVD events among the entire population (HR: 1.54, 95% CI: 1.19-2; P-value< 0.01; HR: 1.53; 95% CI: 1.18-1.98; P < 0.01; HR: 1.57; 95% CI: 1.27-2.03; P < 0.01, respectively). However, after adjusting for confounding factors (age, body mass index [BMI], family history of CVD, smoking status [non-smoker, ex-smoker and current smoker], lipid lowering drug treatment, anti-hypertensive drug treatment, hypertension, healthy eating index [HEI], total energy intake, and presence of diabetes mellitus), a significant direct association only remained between TC and MI risk in men (HR: 2.71; 95%CI: 1.12-6.57; P-value< 0.05). CONCLUSION: In the present study, TC baseline level was significantly associated with the risk of MI among men.


Related Papers

No related papers found

Powered by citation graph analysis